While virtually interacting with civil society organisations (CSOs) and non-governmental organisations (NGOs) on COVID-19 issues at an event organised by Niti Aayog, Health Minister Harsh Vardhan said such organisations have been working tirelessly to ensure essential resources reach the last mile.
Read More
Glenmark will initially enroll 150 patients with mild-to-moderate COVID-19 in a randomized trial that will compare favipiravir with standard supportive care.
Read More
Glenmark is the first pharmaceutical company in India to be given approval by the regulator to start the trial on COVID-19 patients in India.
Read More
Drop in business makes the private healthcare players puts a big question-mark on their survival post-pandemic. Around 70 per cent of the healthcare services in India is provided by private healthcare players
Read More
Turnover rose 19% to 9.09 billion pounds ($11.26 billion) in the three months ended March 31 from a year earlier, while adjusted earnings were 37.7 pence per share.
Read More
Serum, the world’s largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford, which started testing it on humans last week, and is a leader in the global race to develop an antidote to the novel coronavirus.
Read More
European Commission (EC) approved Cosentyx for adult patients with active non-radiographic axial spondyloarthritis (nr-axSpA), characterized by chronic back pain.
Read More
Net income attributable to shareholders fell to $3.40 billion, or 61 cents per share, in the quarter, from $3.88 billion, or 68 cents per share, a year earlier.
Read More
